The analysis of sixty-four mucosal-derived head and neck squamous cell carcinomas (HNSCCs) revealed that Polη expression was elevated in 67% of the samples and that low Polη levels were significantly associated with a high complete response rate after cisplatin treatment 76. Here, POLH is linked to head and neck squamous cell carcinoma.